Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | TC3N5 | — |
Hiberix only diluent portion was administered; Hiberix only diluent portion was administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 4-year-old female patient who received Hib (Hiberix) (batch number TC3N5, expiry date 17-MAR-2026) for prophylaxis. On 24-JUL-2025, the patient received Hiberix. On 24-JUL-2025, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Hiberix only diluent portion was administered) and inappropriate dose of vaccine administered (Verbatim: Hiberix only diluent portion was administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 30-JUL-2025 The registered nurse reported that the patient administered Hiberix, but only diluent portion was administered, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered